Stock-Based Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Stock compensation expense

The Company recorded the following Stock compensation expense in its consolidated statements of income (in thousands):

	Years Ended December 31,
	2021		2020		2019
Stock option grants	$	69		92		112
Restricted stock awards		492		250		—
Employee stock grant		50		530		—
Unrestricted employee stock award		—		—		50
Annual director stock award		500		500		70
	$	1,111		1,372		232

Summary of changes in outstanding options

A Summary of changes in outstanding options is presented below (in thousands, except share and per share amounts):

				Weighted		Weighted		Weighted
	Number			Average		Average		Average
	of			Exercise		Remaining		Grant Date
Options	Shares			Price		Term (yrs)		Fair Value(000's)
Outstanding at January 1, 2019		147,538		$	33.48		6.7	$	1,782
Exercised		(15,034	)	$	30.42			$	(151	)
Outstanding at December 31, 2019		132,504		$	33.82		5.8	$	1,631
Exercised		(12,415	)	$	19.23			$	(100	)
Outstanding at December 31, 2020		120,089		$	35.33		5.3	$	1,531
Exercised		(15,334	)	$	17.54			$	(115	)
Outstanding at December 31, 2021		104,755		$	37.93		4.8	$	1,416
Exercisable at December 31, 2021		96,586		$	37.26		4.7	$	1,281
Vested during twelve months ended  December 31, 2021		4,179						$	69

Summary of stock options outstanding

The following table summarizes information concerning stock options outstanding at December 31, 2021:

	Shares	Weighted			Weighted
Range of Exercise	under	Average			Average
Prices per Share	Option	Exercise Price			Remaining Life
Non-exercisable:
$44.31 - $45.97	8,169		$	45.94		6.9	Years
Exercisable:
$19.68 - $29.52	20,080			22.66		1.7
$29.53 - $44.30	31,130			35.11		4.0
$44.31 - $45.97	45,376			45.19		6.4
	96,586		$	37.26		4.7	Years
Total	104,755		$	37.93		4.8	Years

Summary of changes in restricted stock awards

A Summary of changes in restricted stock awards is presented below (in thousands, except share and per share amounts):

				Weighted		Weighted	Weighted
	Number			Average		Average	Average
	Of			Exercise		Remaining	Grant Date
Restricted stock	Shares			Price		Term (yrs)	Fair Value(000's)
Non-vested at January 1, 2020		0		$	0		$	0
Performance-based awards granted		20,520			46.30			950
Non-vested at December 31, 2020		20,520		$	46.30	3.4	$	950
Time-based awards granted		8,896			45.55			405
Performance-based awards granted		18,882			45.55			860
Vested		(2,224	)		45.55			(101	)
Non-vested at December 31, 2021		46,074		$	45.88	3.1	$	2,114